name:-0.043544054031372
name:-0.059773921966553
name:-0.00058889389038086
Boehringer Ingelheim (Canada) Ltd. Patent Filings

Boehringer Ingelheim (Canada) Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boehringer Ingelheim (Canada) Ltd..The latest application filed is for "viral polymerase inhibitors".

Company Profile
0.50.31
  • Boehringer Ingelheim (Canada) Ltd. - Canada
  • Boehringer Ingelheim Canada Ltd. - Laval Quebec CA
  • Boehringer Ingelheim (Canada) Ltd - Canada
  • Boehringer Ingelheim (Canada) Ltd. - 2100 Cunard Laval CA
  • Boehringer Ingelheim (Canada) Ltd. - 2100 Cunard Street Laval CA
  • Boehringer Ingelheim (Canada) Ltd. - Ridgefield CA H7S 2G5
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Self-replicating RNA molecule from hepatitis C virus
Grant 7,919,312 - Kukolj , et al. April 5, 2
2011-04-05
Hepatitis C inhibitor tri-peptides
Grant RE42,164 - Llinas-Brunet , et al. February 22, 2
2011-02-22
Viral polymerase inhibitors
Grant 7,893,084 - Beaulieu , et al. February 22, 2
2011-02-22
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
Grant 7,838,207 - Pellerin , et al. November 23, 2
2010-11-23
Hepatitis C inhibitor tri-peptides
Grant RE41,894 - Llinas-Brunet , et al. October 26, 2
2010-10-26
Inhibitors of papilloma virus
Grant 7,807,670 - Yoakim , et al. October 5, 2
2010-10-05
Hepatitis C inhibitor tri-peptides
Grant RE41,356 - Llinas-Brunet , et al. May 25, 2
2010-05-25
Viral polymerase inhibitors
Grant 7,576,079 - Beaulieu , et al. August 18, 2
2009-08-18
Inhibitors of papilloma virus
Grant 7,528,167 - Yoakim , et al. May 5, 2
2009-05-05
Viral Polymerase Inhibitors
App 20090087409 - Beaulieu; Pierre Louis ;   et al.
2009-04-02
Viral polymerase inhibitors
Grant 7,439,258 - Beaulieu , et al. October 21, 2
2008-10-21
Hepatitis C inhibitor tri-peptides
Grant RE40,525 - Llinas-Brunet , et al. September 30, 2
2008-09-30
Self-replicating RNA molecule from hepatitis C virus
Grant 7,344,723 - Kukolj , et al. March 18, 2
2008-03-18
RSV polymerase inhibitors
Grant 7,323,567 - Simoneau , et al. January 29, 2
2008-01-29
Direct binding assay for identifying inhibitors of HCV polymerase
Grant 7,294,457 - Kukolj , et al. November 13, 2
2007-11-13
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
Grant 7,276,373 - Pellerin , et al. October 2, 2
2007-10-02
Non-nucleoside reverse transcriptase inhibitors
Grant 7,273,861 - Yoakim , et al. September 25, 2
2007-09-25
Purified active HCV NS2/3 protease
Grant 7,264,811 - Lamarre , et al. September 4, 2
2007-09-04
Purified active HCV NS2/3 protease
App 20070172936 - Thibeault; Diane ;   et al.
2007-07-26
Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
Grant 7,167,801 - Cameron , et al. January 23, 2
2007-01-23
Viral polymerase inhibitors
Grant 7,157,486 - Beaulieu , et al. January 2, 2
2007-01-02
Viral polymerase inhibitors
Grant 7,141,574 - Beaulieu , et al. November 28, 2
2006-11-28
Self-replicating RNA molecule from hepatitis C virus
App 20060246424 - Kukolj; George ;   et al.
2006-11-02
Inhibitors of Papilloma Virus
App 20060235010 - Yoakim; Christiane ;   et al.
2006-10-19
Macrocyclic peptides active against the hepatitis C virus
Grant 7,119,072 - Llinas-Brunet , et al. October 10, 2
2006-10-10
Inhibitors of papilloma virus
Grant 7,119,099 - Yoakim , et al. October 10, 2
2006-10-10
Non-nucleoside reverse transcriptase inhibitors
Grant 7,105,510 - Yoakim , et al. September 12, 2
2006-09-12
Viral polymerase inhibitors
App 20060160798 - Beaulieu; Pierre Louis ;   et al.
2006-07-20
Regions of papilloma virus E1 helicase involved in E1 oligomerization
App 20050287554 - Archambault, Jacques
2005-12-29
RSV polymerase inhibitors
App 20050239814 - Simoneau, Bruno ;   et al.
2005-10-27
Self-replicating RNA molecule from hepatitis C virus
Grant 6,956,117 - Kukolj , et al. October 18, 2
2005-10-18
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
App 20050227226 - Pellerin, Charles ;   et al.
2005-10-13
Regions of papilloma virus E1 helicase involved in E1 oligomerization
Grant 6,916,622 - Archambault July 12, 2
2005-07-12
Methods for determining ATPase activity and uses thereof
Grant 6,852,501 - White February 8, 2
2005-02-08
Inhibitors of papilloma virus
App 20050009855 - Yoakim, Christiane ;   et al.
2005-01-13
E2 displacement assay for identifying inhibitors of HPV
Grant 6,825,176 - White , et al. November 30, 2
2004-11-30
Viral polymerase inhibitors
App 20040224955 - Beaulieu, Pierre Louis ;   et al.
2004-11-11
Purified active HCV NS2/3 protease
Grant 6,815,159 - Thibeault , et al. November 9, 2
2004-11-09
Assay for identifying inhibitors of HIV RT dimerization
Grant 6,811,970 - Sluis-Cremer , et al. November 2, 2
2004-11-02
Self-replicating RNA molecule from hepatitis C virus
App 20040203020 - Kukolj, George ;   et al.
2004-10-14
Viral polymerase inhibitors
Grant 6,794,404 - Beaulieu , et al. September 21, 2
2004-09-21
Self-replicating RNA molecule from hepatitis C virus
App 20040180333 - Kukolj, George ;   et al.
2004-09-16
Hepatitis C inhibitor peptides
Grant 6,767,991 - Llinas-Brunet , et al. July 27, 2
2004-07-27
Non-nucleoside reverse transcriptase inhibitors
App 20040132723 - Yoakim, Christiane ;   et al.
2004-07-08
Inhibitors of papilloma virus
Grant 6,759,409 - Yoakim , et al. July 6, 2
2004-07-06
Non-nucleoside reverse transcriptase inhibitors
App 20040106791 - Yoakim, Christiane ;   et al.
2004-06-03
Non-nucleoside reverse transcriptase inhibitors
Grant 6,716,836 - Ogilvie , et al. April 6, 2
2004-04-06
Viral polymerase inhibitors
App 20040024190 - Beaulieu, Pierre Louis ;   et al.
2004-02-05
Non-nucleoside reverse transcriptase inhibitors
Grant 6,673,791 - Ogilvie , et al. January 6, 2
2004-01-06
Macrocyclic peptides active against the hepatitis C virus
App 20040002448 - Tsantrizos, Youla S. ;   et al.
2004-01-01
Regions of papilloma virus E1 helicase involved in E1 oligomerization
App 20040002059 - Archambault, Jacques
2004-01-01
Viral polymerase inhibitors
App 20030236251 - Beaulieu, Pierre Louis ;   et al.
2003-12-25
Viral polymerase inhibitors
App 20030232816 - Beaulieu, Pierre Louis ;   et al.
2003-12-18
Macrocyclic peptides active against the hepatitis C virus
App 20030224977 - Llinas-Brunet, Montse ;   et al.
2003-12-04
Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents
App 20030226157 - Jianmin, Duan
2003-12-04
E2 displacement assay for identifying inhibitors of HPV
App 20030194698 - White, Peter ;   et al.
2003-10-16
Macrocyclic peptides active against the hepatitis C virus
App 20030181363 - Llinas-Brunet, Montse ;   et al.
2003-09-25
Viral polymerase inhibitors
App 20030176433 - Beaulieu, Pierre Louis ;   et al.
2003-09-18
Non-nucleoside reverse transcriptase inhibitors
App 20030171363 - Ogilvie, William W. ;   et al.
2003-09-11
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
App 20030162168 - Pellerin, Charles ;   et al.
2003-08-28
Surrogate cell-based system and method for assaying the activity of hepatitis C virus NS3 protease
App 20030162169 - Pellerin, Charles ;   et al.
2003-08-28
Macrocyclic peptides active against the hepatitis C virus
Grant 6,608,027 - Tsantrizos , et al. August 19, 2
2003-08-19
Self-replicating RNA molecule from hepatitis C virus
App 20030148348 - Kukolj, George ;   et al.
2003-08-07
Graft animal model for high induction of papillomas, the propagation of papillomavirus and evaluation of candidate therapeutic agents
Grant 6,596,924 - Jianmin July 22, 2
2003-07-22
Direct binding assay for identifying inhibitors of HCV polymerase
App 20030108862 - Kukolj, George ;   et al.
2003-06-12
Assay for identifying inhibitors of HIV RT dimerization
App 20030087379 - Sluis-Cremer, Nicolas ;   et al.
2003-05-08
Human papillomavirus E2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor binding pocket
App 20030082769 - Cameron, Dale R. ;   et al.
2003-05-01
Hepatitis C inhibitor tri-peptides
Grant 6,534,523 - Llinas-Brunet , et al. March 18, 2
2003-03-18
Viral polymerase inhibitors
Grant 6,479,508 - Beaulieu , et al. November 12, 2
2002-11-12
Anti-herpesvirus compounds and methods for identifying, making and using same
Grant 6,458,959 - Crute , et al. October 1, 2
2002-10-01
Viral polymerase inhibitors
Grant 6,448,281 - Beaulieu , et al. September 10, 2
2002-09-10
Hepatitis C inhibitor tri-peptides
Grant 6,420,380 - Llinas-Brunet , et al. July 16, 2
2002-07-16
Hepatitis C inhibitor tri-peptides
Grant 6,410,531 - Llinas-Brunet , et al. June 25, 2
2002-06-25
Hepatitis C inhibitor tri-pepitides
Grant 6,329,417 - Llinas-Brunet , et al. December 11, 2
2001-12-11
Hepatitis C inhibitor tri-peptides
Grant 6,329,379 - Llinas-Brunet , et al. December 11, 2
2001-12-11
Hepatitis C inhibitor tri-peptides
Grant 6,323,180 - Llinas-Brunet , et al. November 27, 2
2001-11-27
Antiherpes tetrapeptide derivatives having a substituted aspartic acid side chain
Grant 6,313,095 - Adams , et al. November 6, 2
2001-11-06
Enzymatic resolution of 1-amino-2-vinylcyclopropyl caboxylic acid methyl ester
Grant 6,268,207 - Bailey July 31, 2
2001-07-31
Azetidinone derivatives for the treatment of HCMV infections
Grant 6,239,125 - Malenfant , et al. May 29, 2
2001-05-29
Azetidinone derivatives for the treatment of HCMV infections
Grant 6,211,170 - Yoakim , et al. April 3, 2
2001-04-03
Hepatitis C inhibitor peptide analogues
Grant 6,143,715 - Llinas-Brunet , et al. November 7, 2
2000-11-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed